GSK3 inhibitors: development and therapeutic potential

By P. Cohen, M. Goedert. Nature reviews. Drug discovery, 2004

781 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis (2005, background): “Consistent with this model of regulation, small cell-perme- able inhibitors of GSK3 with diverse structures stimulate glycogen synthase activity in cell lines or skeletal muscle (reviewed in Cohen and Goedert, 2004).”
Pharmacological inhibitors of glycogen synthase kinase 3. (2004, background): “Insulin-like effects are also observed in vivo [ 15 ,57,58].”
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review) (2017, neutral): “There are also the following subfamilies of protein kinases: AGC, CaMK, CK1, CMGC, STE, TK and TKL (19-27) (Table I).”